Kühn, Anna Luisa
Puri, Ajit S.
Salim, Hamza Adel https://orcid.org/0000-0002-5208-8425
Musmar, Basel
Ghozy, Sherief
Siegler, James
Shaikh, Hamza
Khalife, Jane
Abdalkader, Mohamad
Klein, Piers
Nguyen, Thanh N.
Heit, Jeremy J.
Regenhardt, Robert W.
Diestro, Jose Danilo Bengzon
Cancelliere, Nicole M.
Sweid, Ahmad
Naamani, Kareem El
Hasan, Zuha
Gopinathan, Anil
Amllay, Abdelaziz
Meyer, Lukas
Dusart, Anne
Bellante, Flavio
Forestier, Géraud
Rouchaud, Aymeric
Saleme, Suzana
Mounayer, Charbel
Fiehler, Jens
Dyzmann, Christian
Kan, Peter T.
Singh, Jasmeet
Colasurdo, Marco
Marnat, Gaultier
Berge, Jérôme
Barreau, Xavier
Sibon, Igor
Nedelcu, Simona
Henninger, Nils
Marotta, Thomas R.
Stapleton, Christopher J.
Rabinov, James D.
Ota, Takahiro
Dofuku, Shogo
Yeo, Leonard LL.
Tan, Benjamin Y. Q.
Martinez-Gutierrez, Juan Carlos
Salazar-Marioni, Sergio
Sheth, Sunil
Renieri, Leonardo
Capirossi, Carolina
Mowla, Ashkan
Tjoumakaris, Stavropoula I.
Jabbour, Pascal
Khandelwal, Priyank
Biswas, Arundhati
Clarençon, Frédéric
Elhorany, Mahmoud
Premat, Kevin
Valente, Iacopo
Pedicelli, Alessandro
Filipe, João Pedro
Varela, Ricardo
Quintero-Consuegra, Miguel
Gonzalez, Nestor R.
Möhlenbruch, Markus A.
Jesser, Jessica
Costalat, Vincent
ter Schiphorst, Adrien
Yedavalli, Vivek
Harker, Pablo
Chervak, Lina
Aziz, Yasmin
Gory, Benjamin
Stracke, Christian Paul
Hecker, Constantin
Killer-Oberpfalzer, Monika
Griessenauer, Christoph J.
Thomas, Ajith
Hsieh, Cheng-Yang
Liebeskind, David S.
Radu, Răzvan Alexandru
Alexandre, Andrea M.
Fahed, Robert
Tancredi, Illario
Faizy, Tobias D.
Weyland, Charlotte
Lubicz, Boris
Patel, Aman B.
Pereira, Vitor Mendes
Guenego, Adrien
Dmytriw, Adam A.
,
Article History
Received: 6 January 2024
Revised: 21 June 2024
Accepted: 24 June 2024
First Online: 5 July 2024
Declarations
:
: Dr. Regenhardt serves on a DSMB for a trial sponsored by Rapid Medical, serves as site PI for studies sponsored by Penumbra and Microvention, and receives stroke research grant funding from the National Institutes of Health, Society of Vascular and Interventional Neurology, and Heitman Stroke Foundation. Dr. Guenego reports consultancy for Rapid Medical and Phenox, not directly related to the present work. Dr. Clarençon reports conflicts of interest with Medtronic, Balt Extrusion (consultant), ClinSearch (core lab), Penumbra, Stryker (payment for reading), and Artedrone (Board); all not directly related to the present work. Dr. Henninger received support from CDMRP/DoD W81XWH-19-PRARP-RPA and NINDS NS131756, during the conduct of the study. Dr. Liebeskind is consultant as Imaging Core Lab to Cerenovus, Genentech, Medtronic, Stryker, and Rapid Medical. Dr. Yeo reports Advisory work for AstraZeneca, Substantial support from NMRC Singapore and is a medical advisor for See-mode, Cortiro, and Sunbird Bio, with equity in Ceroflo. All unrelated to the present work. Dr. Griessenauer reports a proctoring agreement with Medtronic and research funding by Penumbra. Dr. Marnat reports conflicts of interest with Microvention Europe, Stryker Neurovascular, Balt (consulting), Medtronic, Johnson & Johnson, and Phenox (paid lectures), all not directly related to the present work. Dr. Puri is a consultant for Medtronic Neurovascular, Stryker NeurovascularBalt, Q’Apel Medical, Cerenovus, Microvention, Imperative Care, Agile, Merit, CereVasc, and Arsenal Medical, and he received research grants from NIH, Microvention, Cerenovus, Medtronic Neurovascular and Stryker Neurovascular, and holds stocks in InNeuroCo, Agile, Perfuze, Galaxy, and NTI. Dr. Tjoumakaris is a consultant for Medtronic and Microvention (funds paid to institution, not personally). Dr. Jabbour is a consultant for Medtronic, Microvention, and Cerus.
: This international, multi-institutional study received approval from the local ethical standards committee at each participating site and informed consent from patients was waived. The study followed the Strengthening the Report of Observational Studies in Epidemiology (STROBE) reporting guidelines [].